A look at Exact Sciences Corporation’s acquisition by Abbott: review EXAS revenue growth, margins, and CRC/MRD screening ...

SOPHiA GENETICS (NASDAQ: SOPH), a global leader in AI-driven precision medicine, and The University of Texas MD Anderson ...

The new Phase III study will test calderasib in a chemo-free regimen for G12C-mutated patients regardless of PD-L1 status.

Agreement expands Cardio Diagnostics' global footprint and supports improved detection and management of coronary heart disease in India.

Across all domains of life, immune defenses foil invading viruses by making it impossible for the viruses to replicate. Most ...

The partnership marks Cardio Diagnostics' first expansion outside the US and is focused on integrating the test within Dr. Lal PathLabs' laboratory and clinical network.

Investing.com -- Sophia Genetics SA (NASDAQ:SOPH) stock rose 4.2% on Wednesday after the AI-driven precision medicine company announced a strategic collaboration with The University of Texas MD ...

Backers claim the tests can predict a child’s risk of autism using a strand of hair or a mother’s blood, but critics say they ...

Cardio Diagnostics Holdings will partner with a longtime distribution leader in India and an Indian network of nearly 300 ...

The ability to move with speed, precision and power is important for longevity. Here’s how to gauge it and how to improve.

The University of Texas MD Anderson Cancer Center and SOPHiA GENETICS today announced a strategic collaboration that unites SOPHiA GENETICS’ AI-powered analytics with MD Anderson’s clinical and ...

Physical AI describes intelligent systems that can sense, interpret, and act in real environments. Think of self-driving cars ...